# Vis-Rx Post-Market Evaluation

> **NCT04533503** · — · COMPLETED · sponsor: **Gentuity, LLC** · enrollment: 257 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** HF-OCT Imaging with the Vis-Rx Micro-Imaging Catheter

## Key facts

- **NCT ID:** NCT04533503
- **Lead sponsor:** Gentuity, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-22
- **Primary completion:** 2023-01-25
- **Final completion:** 2023-01-25
- **Target enrollment:** 257 (ACTUAL)
- **Last updated:** 2025-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04533503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04533503, "Vis-Rx Post-Market Evaluation". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04533503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*